Accuracy and Limitations of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients with Positive Nodes.
Sofia Aragon-SanchezM Reyes Oliver-PerezAinhoa MadariagaM Jose TabuencaMario MartinezAlberto Galindo IzquierdoM Luisa ArroyoMarta GallegoMarta BlancoEva Ciruelos GilPublished in: The breast journal (2022)
In this cohort, the SLN assessment was associated with an adequate DR and a high FNR. Removing three or more SLNs decreased the FNR from 19.1% to 8.7%. Complementary approaches may be considered for axillary lymph node staging after neoadjuvant chemotherapy. The study was approved by our institution's ethics committee (Instituto de Investigacion Sanitaria Hospital 12 de Octubre (imas12), Universidad Complutense de Madrid, Madrid, Spain) (https://clinicaltrials.gov/ct2/show/NCEI:20/0048).
Keyphrases
- sentinel lymph node
- neoadjuvant chemotherapy
- lymph node
- locally advanced
- public health
- healthcare
- ultrasound guided
- squamous cell carcinoma
- emergency department
- contrast enhanced
- magnetic resonance imaging
- fine needle aspiration
- acute care
- adverse drug
- dual energy
- machine learning
- artificial intelligence
- deep learning
- drug administration